R&D Strategy
REYON Pharmaceuticals is conducting in-house R&D based on the development and manufacturing capabilities represented by organic synthesis and fermentation technology and the comprehensive production platform for bio and chemical drugs, as well as cooperative R&D with partner companies.
Building a Platform Centered on Production Technology and Infrastructure
In-house
- API
- Generics
- New drugs
- Platform
Co-development
- Forming various partnerships that actively utilize production infrastructure
- Continuous discovery of new pipelines and cooperation
- Targeting rare, chronic, and intractable diseases
- initial venture Incubating
Global Comprehensive Production Platform
Central R&D Center
REYON Pharmaceutical Co., Ltd. Central Research Institute was established in 1988 with the corporate philosophy of investigating the principles of life.
Based on our exceptional expertise accumulated over 60 years, we are conducting research in the fields of biopharmaceuticals, chemicals, and natural medicines to overcome various diseases.
The Central Research Institute is constantly conducting research and development as the cornerstone and foundation to enable REYON Pharmaceutical to make the leap to become a global pharmaceutical company specializing in bio and chemical pharmaceuticals.
All rights Reserved.